United States
Germany
Japan
United Kingdom
China
TP53 mouse monoclonal antibody, clone OTI5D9 (formerly 5D9)
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey |
Antibodies
TP53 mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey, Mouse |
TP53 mouse monoclonal antibody, clone OTI2E4 (formerly 2E4)
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey, Mouse |
BAX (3-16) mouse monoclonal antibody, clone 2D2, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
BAX (3-16) mouse monoclonal antibody, clone 2D2, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
Purified P53 (TP53) mouse monoclonal antibody, clone UMAB19
| Applications | IHC, WB |
| Reactivities | Human, Monkey |
TP53 mouse monoclonal antibody, clone OTI3G9 (formerly 3G9)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
MAP2K3 (MEK3) mouse monoclonal antibody, clone OTI5F2 (formerly 5F2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
TP53 mouse monoclonal antibody, clone OTI2A4 (formerly 2A4)
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey |
TP53 mouse monoclonal antibody, clone OTI5B2 (formerly 5B2)
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey |
TP53 mouse monoclonal antibody, clone OTI1E1 (formerly 1E1)
| Applications | IHC, WB |
| Reactivities | Human, Monkey |
MAPK13 (SAPK4) mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K3 (MEK3) mouse monoclonal antibody, clone OTI1D2 (formerly 1D2)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K3 (MEK3) mouse monoclonal antibody, clone OTI2G3 (formerly 2G3)
| Applications | IF, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
MAPK13 (SAPK4) mouse monoclonal antibody, clone OTI2G1 (formerly 2G1)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
